SCHEMBL21384564

SCHEMBL21384564

O=C(O)c1cc(Br)ccc1NS(=O)(=O)C1CC1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
METAP2 P50579 3/20 0.56
ALDH1A1 P00352 2/20 0.50
ACLY P53396 2/20 0.50
KDM1A O60341 1/20 0.49
APEX1 P27695 1/20 0.48
MEN1 O00255 3/20 0.47
KMT2A Q03164 3/20 0.47
KDM4E B2RXH2 3/20 0.47
TDP1 Q9NUW8 2/20 0.47
PLA2G1B P04054 1/20 0.47
MAPT P10636 1/20 0.47
HPGD P15428 1/20 0.47
ATG4B Q9Y4P1 1/20 0.47
AKR1C4 P17516 1/20 0.44
AKR1C3 P42330 1/20 0.44
AKR1C2 P52895 1/20 0.44
AKR1C1 Q04828 1/20 0.44
POLB P06746 1/20 0.44
WDR5 P61964 1/20 0.44
CYP3A4 P08684 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13337363 0.85 ALDH1A1 (0.49) METAP2ALDH1A1KDM4EMRGPRX1TSPO
SCHEMBL21381491 0.84 ACLY (0.61) METAP2ACLYKDM4EMRGPRX1
SCHEMBL219601 0.81 ALDH1A1 (0.71) METAP2ALDH1A1KDM1AAPEX1MEN1
SCHEMBL31393942 0.78 ACLY (0.62) ALDH1A1ACLYMEN1KMT2AKDM4E
SCHEMBL21384569 0.77 ACLY (0.48) ACLYKDM4ETDP1MRGPRX1TSPO
SCHEMBL23141230 0.75 METAP2 (0.60) METAP2ALDH1A1KDM1AAPEX1MEN1
SCHEMBL31046908 0.75 METAP2 (0.60) METAP2ALDH1A1KDM1AAPEX1MEN1
SCHEMBL3377038 0.74 ACLY (0.60) ACLYCYP3A4CYP2C9CYP2C19MRGPRX1
SCHEMBL13337359 0.73 KIF11 (0.36) ALDH1A1ACLYTDP1WDR5MRGPRX1
SCHEMBL21394417 0.73 MRGPRX1 (0.53) KDM1AMRGPRX1TSPO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2019179436-A1 ACID AMIDE COMPOUND AND USE THEREOF IN TREATMENT OF CANCERS 成都海创药业有限公司 2019-09-26 WO disclosed